ProFinder
Go Pro...

Xiao‐Jun Huang

Position not listed

Peking University · Beijing

Source

OpenAlex

Verification

Academic database source — not independently verified

Unverified

On file

Email
Not publicly verified
ORCID
0000-0002-2145-6643
Lab or group
Not publicly verified
Supervision
Not publicly verified
Last updated
2026-10-05

Research areas

Not available

Research interests

Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Immune Cell Function and Interaction

Funding

Unknown

Not publicly verified. No grant, project, or funded-student record is stored.

Research timeline

Newest stored year: 2026. Topics on file: Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Immune Cell Function and Interaction.

2026

  • Age‐Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review (2026)
  • Hematopoietic stem cell transplantation for acquired aplastic anemia in 2024: Report from the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG) (2026)
  • Incidence and risk factors of Epstein-Barr virus infection and post-transplant lymphoproliferative disorder in paediatric haploidentical allogeneic hematopoietic stem cell transplantation (2026)
  • NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor (2026)
  • Single-cell mapping of thymus-dependent naïve t-cell regeneration reveals CD61-associated states after hematopoietic stem cell transplantation (2026)

Papers linked only by a name match stay hidden.

Research match score

Sign in to see your personalized research match.

Target: Low priority

  • Research fit is not included until you sign in and save research interests.
  • Affiliation is not verified.
  • No email is stored.
  • A stored publication year is 2026.
  • Funding evidence is unknown, so it does not raise the priority.

Match, then draft, then copy. Mark Contacted on the tracker. Follow up only after you send it yourself.

Sign in